Top

Reactions Weekly

Published in:

01-03-2024 | Cetuximab | Case report

Cetuximab

Acute-coronary-syndrome

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Yhim H, et al. Risk of Venous and Arterial Thromboembolism in Recurrent/Metastatic Colorectal Cancer Patients Receiving First-Line Cetuximab-Based Combination Therapy: A Korean Population-Based Study. Research and Practice in Thrombosis and Haemostasis 7 (Suppl. 2): abstr. PB0946, Oct 2023. Available from: URL: https://dx.doi.org/10.1016/j.rpth.2023.101743 [abstract]

Title: Cetuximab
Acute-coronary-syndrome
Publication date: 01-03-2024
Publisher: Springer International Publishing
Keywords: Cetuximab
Colorectal Cancer
Colorectal Cancer
Acute Coronary Syndrome
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-53989-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cetuximab

Acute-coronary-syndrome

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Methylprednisolone-sodium-succinate

Amoxicillin

Gemtuzumab-ozogamicin

Antineoplastics

Tivozanib

Multiple drugs